Summary:
This study will assess the effect of the
investigational product on the rate of
moderate or severe COPD exacerbations
Qualified Participants Must:
• Be diagnosed with COPD
•
Be between 40 and 80 years of age
•
Be a former or current cigarette smoker
•
Have a current COPD maintenance therapy
•
Have a history of exacerbation within the last 12 months
Qualified Participants May Receive:
Study drug at NO COST, Study-related medical care at NO COST, and Compensation for time and travel.